PMID- 23083128 OWN - NLM STAT- MEDLINE DCOM- 20130207 LR - 20220129 IS - 1471-4159 (Electronic) IS - 0022-3042 (Print) IS - 0022-3042 (Linking) VI - 124 IP - 1 DP - 2013 Jan TI - SMRT-mediated co-shuttling enables export of class IIa HDACs independent of their CaM kinase phosphorylation sites. PG - 26-35 LID - 10.1111/jnc.12058 [doi] AB - The Class IIa histone deacetylases (HDAC)4 and HDAC5 play a role in neuronal survival and behavioral adaptation in the CNS. Phosphorylation at 2/3 N-terminal sites promote their nuclear export. We investigated whether non-canonical signaling routes to Class IIa HDAC export exist because of their association with the co-repressor Silencing Mediator Of Retinoic And Thyroid Hormone Receptors (SMRT). We found that, while HDAC5 and HDAC4 mutants lacking their N-terminal phosphorylation sites (HDAC4(MUT), HDAC5(MUT)) are constitutively nuclear, co-expression with SMRT renders them exportable by signals that trigger SMRT export, such as synaptic activity, HDAC inhibition, and Brain Derived Neurotrophic Factor (BDNF) signaling. We found that SMRT's repression domain 3 (RD3) is critical for co-shuttling of HDAC5(MUT), consistent with the role for this domain in Class IIa HDAC association. In the context of BDNF signaling, we found that HDAC5(WT), which was more cytoplasmic than HDAC5(MUT), accumulated in the nucleus after BDNF treatment. However, co-expression of SMRT blocked BDNF-induced HDAC5(WT) import in a RD3-dependent manner. In effect, SMRT-mediated HDAC5(WT) export was opposing the BDNF-induced HDAC5 nuclear accumulation observed in SMRT's absence. Thus, SMRT's presence may render Class IIa HDACs exportable by a wider range of signals than those which simply promote direct phosphorylation. CI - (c) 2012 International Society for Neurochemistry. FAU - Soriano, Francesc X AU - Soriano FX AD - Centre for Integrative Physiology, University of Edinburgh, Edinburgh, UK. f.x.soriano@ub.edu FAU - Chawla, Sangeeta AU - Chawla S FAU - Skehel, Paul AU - Skehel P FAU - Hardingham, Giles E AU - Hardingham GE LA - eng GR - 087491/Wellcome Trust/United Kingdom GR - BB/D011388/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom GR - G0902044/MRC_/Medical Research Council/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20121115 PL - England TA - J Neurochem JT - Journal of neurochemistry JID - 2985190R RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Histone Deacetylase Inhibitors) RN - 0 (Hydroxamic Acids) RN - 0 (Nuclear Receptor Co-Repressor 2) RN - 0 (silencing mediator of retinoic acid and thyroid hormone receptors, rat) RN - 147336-22-9 (Green Fluorescent Proteins) RN - 3X2S926L3Z (trichostatin A) RN - EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinases) RN - EC 3.5.1.98 (Histone Deacetylases) SB - IM MH - Animals MH - Brain-Derived Neurotrophic Factor/metabolism/pharmacology MH - Calcium-Calmodulin-Dependent Protein Kinases/genetics/*metabolism MH - Cells, Cultured MH - Cerebral Cortex/cytology MH - Embryo, Mammalian MH - Green Fluorescent Proteins/genetics MH - Histone Deacetylase Inhibitors/pharmacology MH - Histone Deacetylases/genetics/*metabolism MH - Hydroxamic Acids/pharmacology MH - Mutation/genetics MH - Neurons MH - Nuclear Receptor Co-Repressor 2/genetics/*metabolism MH - Phosphorylation/physiology MH - Protein Transport/drug effects/genetics MH - Rats MH - Rats, Sprague-Dawley MH - Signal Transduction/drug effects/genetics MH - Transfection PMC - PMC3557716 EDAT- 2012/10/23 06:00 MHDA- 2013/02/08 06:00 CRDT- 2012/10/23 06:00 PHST- 2012/05/30 00:00 [received] PHST- 2012/09/28 00:00 [revised] PHST- 2012/10/07 00:00 [accepted] PHST- 2012/10/23 06:00 [entrez] PHST- 2012/10/23 06:00 [pubmed] PHST- 2013/02/08 06:00 [medline] AID - 10.1111/jnc.12058 [doi] PST - ppublish SO - J Neurochem. 2013 Jan;124(1):26-35. doi: 10.1111/jnc.12058. Epub 2012 Nov 15.